Wall Street drifts lower after sudden jump
Early yesterday afternoon, all the major US stock indices were little changed. They had rallied off lows hit at the end of the Asian-Pacific session, yet sentiment was still quite negative following three consecutive negative sessions for all the majors. But suddenly, they all turned sharply higher following an announcement from the US Treasury saying it would double, at least, its longer-term debt repurchases. The news comes as investors are getting increasingly nervous about global government debt levels.

Source: TN Trader
The US fiscal deficit was over $432 billion in July, its highest since March 2021 during the Covid crisis. This has seen the national debt cross $40 trillion, boosted by a mixture of Covid spending, tax cuts and war. This comes on top of concerns over AI infrastructure spending and rising inflation. Understandably, some analysts are questioning how such debt can be brought under control, given the ever-growing cost of servicing it.
The Treasury's news, which is effectively a rearrangement of Treasury maturity schedules, led to a slump in the US dollar as global bond yields, particularly at the long end, fell sharply, pulling back from multi-year highs. Other markets reacted violently as well, with sharp rallies in precious metals as traders reacted to the US dollar selloff.
The news certainly brought some relief for investors who were getting increasingly rattled by the tech-led decline across US equities. But it's worth pointing out that the snapback was perhaps not as strong as it could have been, given bigger reactions across other risk assets.
It's also worth noting that the rally soon began to peter out, and the sellers were encouraged further by the release of a hawkish set of minutes from the Federal Reserve's last FOMC meeting. The key takeaway from these was that many members remain concerned about persistent upside inflationary pressures with some significant support for future rate hikes.
Meanwhile, healthcare stocks got a boost after Moderna surged nearly 177% on positive trial results for a personalised mRNA cancer therapy developed with Merck. By mid-morning on Thursday, all the US majors were drifting lower once again. It's worth noting that S&P volatility, as measured by the VIX, suggests that investors seem remarkably unbothered by the possibility of a significant downside correction across equities.
Are they being overly complacent? After all, a subdued VIX doesn't mean that it's safe to load up on stocks, given the danger that a single negative event can send the crowd of investors rushing from one side of the boat to the other.

















